A Critical Review of PET Tracers Used for Brain Tumor Imaging

被引：8
|
作者：
Borja, Austin J. [1 ,2 ]
Hancin, Emily C. [1 ,3 ]
Raynor, William Y. [1 ,4 ]
Ayubcha, Cyrus [1 ,5 ]
Detchou, Donald K. [1 ,2 ]
Werner, Thomas J. [1 ]
Revheim, Mona-Elisabeth [1 ]
Alavi, Abass [1 ,6 ,7 ]
机构：
[1] Hosp Univ Penn, Dept Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA
[3] Temple Univ, Lewis Katz Sch Med, 3500 North Broad St, Philadelphia, PA 19140 USA
[4] Drexel Univ, Coll Med, 2900 West Queen Lane, Philadelphia, PA 19129 USA
[5] Harvard Med Sch, 25 Shattuck St, Boston, MA 02115 USA
[6] Oslo Univ Hosp, Div Radiol & Nucl Med, Sognsvannsveien 20, N-0372 Oslo, Norway
[7] Univ Oslo, Inst Clin Med, Fac Med, Problemveien 7, N-0315 Oslo, Norway
来源：
PET CLINICS | 2021年 / 16卷 / 02期
关键词：
Brain neoplasms; Neuroimaging; PET; F-18-flurodeoxyglucose; POSITRON-EMISSION-TOMOGRAPHY; CENTRAL-NERVOUS-SYSTEM; HEALTH-ORGANIZATION CLASSIFICATION; AMINO-ACID PET; DIFFERENTIATING RECURRENT; RADIATION NECROSIS; F-18; FLUORODEOXYGLUCOSE; SOMATOSTATIN RECEPTORS; GA-68-PSMA PET/CT; CONTRAST AGENTS;
D O I：
10.1016/j.cpet.2020.12.004
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The brain is a common site for metastases as well as primary tumors. Although evaluation of these malignancies with contrast-enhanced MR imaging defines current clinical practice, 18F-fluorodeoxyglucose (FDG)-PET has shown considerable utility in this area. In addition, many other tracers targeting various aspects of tumor biology have been developed and tested. This article discusses recent developments in PET imaging and the anticipated role of FDG and other tracers in the assessment of brain tumors. © 2020 Elsevier Inc.
引用
收藏
页码：219 / 231
页数：13
相关论文
共 50 条
  • [41] Diagnostic Accuracy of PET Tracers for the Differentiation of Tumor Progression from Treatment-Related Changes in High-Grade Glioma: A Systematic Review and Metaanalysis
    de Zwart, Paul L.
    van Dijken, Bait R. J.
    Holtman, Gea A.
    Stormezand, Gilles N.
    Dierckx, Rudi A. J. O.
    van Laar, Peter Jan
    van der Hoorn, Anouk
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (04) : 498 - 504
  • [42] Role of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain Tumors
    Borja, Austin J.
    Saini, Jitender
    Raynor, William Y.
    Ayubcha, Cyrus
    Werner, Thomas J.
    Alavi, Abass
    Revheim, Mona-Elisabeth
    Nagaraj, Chandana
    PET CLINICS, 2022, 17 (03) : 431 - 451
  • [43] A Comparison of the Imaging Characteristics and Microregional Distribution of 4 Hypoxia PET Tracers
    Carlin, Sean
    Zhang, Hanwen
    Reese, Megan
    Ramos, Nicholas N.
    Chen, Qing
    Ricketts, Sally-Ann
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (03) : 515 - 521
  • [44] PET and SPECT imaging of the brain: a review on the current status of nuclear medicine in Japan
    Kaneta, Tomohiro
    JAPANESE JOURNAL OF RADIOLOGY, 2020, 38 (04) : 343 - 357
  • [45] PET/MR Imaging: A Critical Appraisal
    Weber, Wolfgang A.
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 : 56S - 58S
  • [46] PET radiotracers for molecular imaging in the brain: Past, present and future
    Zimmer, Luc
    Luxen, Andre
    NEUROIMAGE, 2012, 61 (02) : 363 - 370
  • [47] PET probes for imaging brain acetylcholinesterase
    Kikuchi, Tatsuya
    Okamura, Toshimitsu
    Zhang, Ming-Rong
    Irie, Toshiaki
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 (3-4) : 172 - 179
  • [48] PET Imaging for Traumatic Brain Injury
    Dubroff, Jacob G.
    Newberg, Andrew B.
    PET CLINICS, 2010, 5 (02) : 199 - +
  • [49] PET imaging with hypoxia tracers: a must in radiation therapy
    Giovanni Lucignani
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 838 - 842
  • [50] Small-molecule PET Tracers for Imaging Proteinopathies
    Mathis, Chester A.
    Lopresti, Brian J.
    Ikonomovic, Milos D.
    Klunk, William E.
    SEMINARS IN NUCLEAR MEDICINE, 2017, 47 (05) : 553 - 575
12345